U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07575984) titled 'Mexidol(R) Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke' on May 04.
Brief Summary: The primary objective of this study is to further define the mechanisms of action of Mexidol(R) (solution for intravenous and intramuscular injection, 50 mg/ml) and Mexidol(R) FORTE 250 (film-coated tablets, 250 mg) in the hyperacute and acute periods of ischemic stroke, and to evaluate their impact on clinical and neuroimaging outcomes of the disease.
Study Start Date: Nov. 04, 2025
Study Type: INTERVENTIONAL
Condition:
Ischemic Stroke, Hyperacute
Ischemic Stroke, Acute
Cerebrovascular Accident (Stroke)
Intervention:
D...